Literature DB >> 8764088

Human cytomegalovirus (HCMV) smallest capsid protein identified as product of short open reading frame located between HCMV UL48 and UL49.

W Gibson1, K S Clopper, W J Britt, M K Baxter.   

Abstract

The capsid of cytomegalovirus contains an abundant, low-molecular-weight protein whose coding sequence within the viral genome had not been identified. We have used a combination of biochemical and immunological techniques to demonstrate that this protein, called the smallest capsid protein in human cytomegalovirus, is encoded by a previously unidentified 225-bp open reading frame (ORF) located between ORFs UL48 and UL49. This short ORF, called UL48/49, is the positional homolog of herpes simplex virus ORF UL35 (encoding capsid protein VP26) and shows partial amino acid sequence identity to positional homologs in human herpes viruses 6 and 7.

Entities:  

Mesh:

Year:  1996        PMID: 8764088      PMCID: PMC190534     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Posttranslational modification and subcellular localization of the p12 capsid protein of herpes simplex virus type 1.

Authors:  D S McNabb; R J Courtney
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  The 45-kilodalton protein of cytomegalovirus (Colburn) B-capsids is an amino-terminal extension form of the assembly protein.

Authors:  P Schenk; A S Woods; W Gibson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 3.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Identification of precursor to cytomegalovirus capsid assembly protein and evidence that processing results in loss of its carboxy-terminal end.

Authors:  W Gibson; A I Marcy; J C Comolli; J Lee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Structural and nonstructural proteins of strain Colburn cytomegalovirus.

Authors:  W Gibson
Journal:  Virology       Date:  1981-06       Impact factor: 3.616

Review 6.  Selection of particles and proteins for use as human cytomegalovirus subunit vaccines.

Authors:  W Gibson; A Irmiere
Journal:  Birth Defects Orig Artic Ser       Date:  1984

7.  Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

Authors:  A Irmiere; W Gibson
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

8.  Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2.

Authors:  G H Cohen; M Ponce de Leon; H Diggelmann; W C Lawrence; S K Vernon; R J Eisenberg
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

9.  Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles.

Authors:  A Irmiere; W Gibson
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

10.  Identification and characterization of the herpes simplex virus type 1 virion protein encoded by the UL35 open reading frame.

Authors:  D S McNabb; R J Courtney
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more
  23 in total

1.  Capsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaherpesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirus.

Authors:  B L Trus; J B Heymann; K Nealon; N Cheng; W W Newcomb; J C Brown; D H Kedes; A C Steven
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Reevaluation of human cytomegalovirus coding potential.

Authors:  Eain Murphy; Isidore Rigoutsos; Tetsuo Shibuya; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

3.  Three-dimensional localization of the smallest capsid protein in the human cytomegalovirus capsid.

Authors:  Xuekui Yu; Sanket Shah; Ivo Atanasov; Pierrette Lo; Fenyong Liu; William J Britt; Z Hong Zhou
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Proteins associated with purified human cytomegalovirus particles.

Authors:  C J Baldick; T Shenk
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Hexon-only binding of VP26 reflects differences between the hexon and penton conformations of VP5, the major capsid protein of herpes simplex virus.

Authors:  P T Wingfield; S J Stahl; D R Thomsen; F L Homa; F P Booy; B L Trus; A C Steven
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Cytomegalovirus "missing" capsid protein identified as heat-aggregable product of human cytomegalovirus UL46.

Authors:  W Gibson; M K Baxter; K S Clopper
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Genetic evidence of an essential role for cytomegalovirus small capsid protein in viral growth.

Authors:  E M Borst; S Mathys; M Wagner; W Muranyi; M Messerle
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Capsid structure of simian cytomegalovirus from cryoelectron microscopy: evidence for tegument attachment sites.

Authors:  B L Trus; W Gibson; N Cheng; A C Steven
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Nuclear localization sequences in cytomegalovirus capsid assembly proteins (UL80 proteins) are required for virus production: inactivating NLS1, NLS2, or both affects replication to strikingly different extents.

Authors:  Nang L Nguyen; Amy N Loveland; Wade Gibson
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Identification of proteins associated with murine cytomegalovirus virions.

Authors:  Lisa M Kattenhorn; Ryan Mills; Markus Wagner; Alexandre Lomsadze; Vsevolod Makeev; Mark Borodovsky; Hidde L Ploegh; Benedikt M Kessler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.